Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	medium-chain fatty acid omega-hydroxylase activity	CYP4A11 CYP4A22	5.90e-06	2	49	2	GO:0140981
GeneOntologyMolecularFunction	16-hydroxypalmitate dehydrogenase activity	CYP4A11 CYP4A22	5.90e-06	2	49	2	GO:0103002
GeneOntologyMolecularFunction	minus-end-directed microtubule motor activity	DNHD1 DYNC2H1 DYNC1H1	1.10e-05	18	49	3	GO:0008569
GeneOntologyMolecularFunction	dynein light intermediate chain binding	DNHD1 DYNC2H1 DYNC1H1	4.36e-05	28	49	3	GO:0051959
GeneOntologyMolecularFunction	dynein intermediate chain binding	DNHD1 DYNC2H1 DYNC1H1	1.02e-04	37	49	3	GO:0045505
GeneOntologyMolecularFunction	leukotriene-B4 20-monooxygenase activity	CYP4A11 CYP4A22	1.23e-04	7	49	2	GO:0050051
GeneOntologyMolecularFunction	alkane 1-monooxygenase activity	CYP4A11 CYP4A22	1.23e-04	7	49	2	GO:0018685
GeneOntologyMolecularFunction	arachidonate omega-hydroxylase activity	CYP4A11 CYP4A22	2.62e-04	10	49	2	GO:0052869
GeneOntologyMolecularFunction	fatty acid omega-hydroxylase activity	CYP4A11 CYP4A22	2.62e-04	10	49	2	GO:0120250
GeneOntologyMolecularFunction	long-chain fatty acid omega-hydroxylase activity	CYP4A11 CYP4A22	2.62e-04	10	49	2	GO:0102033
GeneOntologyMolecularFunction	oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen	CYP4A11 CYP4A22	4.52e-04	13	49	2	GO:0016713
GeneOntologyMolecularFunction	arachidonate binding	CYP4A11 CYP4A22	6.07e-04	15	49	2	GO:0050544
GeneOntologyMolecularFunction	microtubule motor activity	DNHD1 DYNC2H1 DYNC1H1	6.77e-04	70	49	3	GO:0003777
GeneOntologyMolecularFunction	neurexin family protein binding	NLGN4X NLGN4Y	6.93e-04	16	49	2	GO:0042043
GeneOntologyMolecularFunction	icosanoid binding	CYP4A11 CYP4A22	6.93e-04	16	49	2	GO:0050542
GeneOntologyMolecularFunction	icosatetraenoic acid binding	CYP4A11 CYP4A22	6.93e-04	16	49	2	GO:0050543
GeneOntologyMolecularFunction	chloride ion binding	NLGN4X NLGN4Y	6.93e-04	16	49	2	GO:0031404
GeneOntologyMolecularFunction	arachidonate epoxygenase activity	CYP4A11 CYP4A22	1.57e-03	24	49	2	GO:0008392
GeneOntologyMolecularFunction	arachidonate monooxygenase activity	CYP4A11 CYP4A22	1.99e-03	27	49	2	GO:0008391
GeneOntologyMolecularFunction	long-chain fatty acid binding	CYP4A11 CYP4A22	2.14e-03	28	49	2	GO:0036041
GeneOntologyMolecularFunction	cytoskeletal motor activity	DNHD1 DYNC2H1 DYNC1H1	3.04e-03	118	49	3	GO:0003774
GeneOntologyMolecularFunction	aromatase activity	CYP4A11 CYP4A22	3.33e-03	35	49	2	GO:0070330
GeneOntologyMolecularFunction	ATP-dependent activity	DNHD1 DYNC2H1 ACSM1 MLH1 DYNC1H1 TDRD12	3.75e-03	614	49	6	GO:0140657
GeneOntologyBiologicalProcess	lauric acid metabolic process	CYP4A11 CYP4A22	1.94e-05	3	53	2	GO:0048252
GeneOntologyBiologicalProcess	territorial aggressive behavior	NLGN4X NLGN4Y	1.94e-05	3	53	2	GO:0002124
GeneOntologyBiologicalProcess	male courtship behavior	NLGN4X NLGN4Y	3.87e-05	4	53	2	GO:0008049
GeneOntologyBiologicalProcess	cilium movement	DNHD1 DYNC2H1 BBS4 KATNIP DYNC1H1 IQUB	5.41e-05	261	53	6	GO:0003341
GeneOntologyBiologicalProcess	courtship behavior	NLGN4X NLGN4Y	1.35e-04	7	53	2	GO:0007619
GeneOntologyBiologicalProcess	regulation of SREBP signaling pathway	AMFR INSIG1	1.80e-04	8	53	2	GO:2000638
GeneOntologyBiologicalProcess	brainstem development	NLGN4X NLGN4Y	1.80e-04	8	53	2	GO:0003360
GeneOntologyCellularComponent	symmetric, GABA-ergic, inhibitory synapse	NLGN4X NLGN4Y	3.77e-05	4	53	2	GO:0098983
GeneOntologyCellularComponent	T cell receptor complex	TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	5.75e-05	163	53	5	GO:0042101
GeneOntologyCellularComponent	motile cilium	DNHD1 DYNC2H1 BBS4 CATSPERB PRAMEF2 IQUB	2.69e-04	355	53	6	GO:0031514
GeneOntologyCellularComponent	dynein complex	DNHD1 DYNC2H1 DYNC1H1	3.48e-04	54	53	3	GO:0030286
GeneOntologyCellularComponent	cell surface	PXDN NLGN4X NRDC NLGN4Y TRGV2 TRGV3 TRGV4 KCNMA1 TRGV5 TRPM8	4.17e-04	1111	53	10	GO:0009986
GeneOntologyCellularComponent	symmetric synapse	NLGN4X NLGN4Y	4.83e-04	13	53	2	GO:0032280
GeneOntologyCellularComponent	microtubule associated complex	DNHD1 FNTA DYNC2H1 DYNC1H1	7.40e-04	161	53	4	GO:0005875
GeneOntologyCellularComponent	membrane protein complex	AMFR STXBP5L PIK3CD INSIG1 TRGV2 TRGV3 TRGV4 KCNMA1 TRGV5 TRGV10 CATSPERB	1.14e-03	1498	53	11	GO:0098796
GeneOntologyCellularComponent	glycinergic synapse	NLGN4X NLGN4Y	1.16e-03	20	53	2	GO:0098690
GeneOntologyCellularComponent	asymmetric, glutamatergic, excitatory synapse	NLGN4X NLGN4Y	1.68e-03	24	53	2	GO:0098985
GeneOntologyCellularComponent	cytoplasmic dynein complex	DYNC2H1 DYNC1H1	1.68e-03	24	53	2	GO:0005868
GeneOntologyCellularComponent	plasma membrane signaling receptor complex	TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	1.90e-03	350	53	5	GO:0098802
GeneOntologyCellularComponent	external side of plasma membrane	TRGV2 TRGV3 TRGV4 KCNMA1 TRGV5 TRPM8	1.94e-03	519	53	6	GO:0009897
GeneOntologyCellularComponent	inhibitory synapse	NLGN4X NLGN4Y	2.80e-03	31	53	2	GO:0060077
GeneOntologyCellularComponent	9+2 motile cilium	DNHD1 DYNC2H1 CATSPERB IQUB	3.10e-03	238	53	4	GO:0097729
GeneOntologyCellularComponent	plasma membrane protein complex	TRGV2 TRGV3 TRGV4 KCNMA1 TRGV5 TRGV10 CATSPERB	3.51e-03	785	53	7	GO:0098797
MousePheno	increased renal vascular resistance	CYP4A11 CYP4A22	7.16e-05	5	38	2	MP:0005531
MousePheno	abnormal renal sodium reabsorption	CYP4A11 CYP4A22	7.16e-05	5	38	2	MP:0010109
MousePheno	abnormal renal reabsorption	CYP4A11 KCNMA1 CYP4A22	1.14e-04	35	38	3	MP:0010107
MousePheno	abnormal renal vascular resistance	CYP4A11 CYP4A22	1.99e-04	8	38	2	MP:0005529
MousePheno	abnormal renal sodium ion transport	CYP4A11 CYP4A22	1.99e-04	8	38	2	MP:0011442
Domain	Dynein_HC_stalk	DNHD1 DYNC2H1 DYNC1H1	5.68e-06	14	48	3	IPR024743
Domain	Dynein_heavy_dom-2	DNHD1 DYNC2H1 DYNC1H1	5.68e-06	14	48	3	IPR013602
Domain	DHC_N2	DNHD1 DYNC2H1 DYNC1H1	5.68e-06	14	48	3	PF08393
Domain	MT	DNHD1 DYNC2H1 DYNC1H1	5.68e-06	14	48	3	PF12777
Domain	NLGN4	NLGN4X NLGN4Y	6.47e-06	2	48	2	IPR030025
Domain	DHC_fam	DNHD1 DYNC2H1 DYNC1H1	7.09e-06	15	48	3	IPR026983
Domain	Dynein_heavy_dom	DNHD1 DYNC2H1 DYNC1H1	7.09e-06	15	48	3	IPR004273
Domain	Dynein_heavy	DNHD1 DYNC2H1 DYNC1H1	7.09e-06	15	48	3	PF03028
Domain	Nlgn	NLGN4X NLGN4Y	6.44e-05	5	48	2	IPR000460
Domain	Dynein_heavy_dom-1	DYNC2H1 DYNC1H1	1.79e-04	8	48	2	IPR013594
Domain	DHC_N1	DYNC2H1 DYNC1H1	1.79e-04	8	48	2	PF08385
Domain	Carboxylesterase_B_CS	NLGN4X NLGN4Y	4.95e-04	13	48	2	IPR019819
Domain	ATPase_dyneun-rel_AAA	DYNC2H1 DYNC1H1	5.77e-04	14	48	2	IPR011704
Domain	Dynein_heavy_chain_D4_dom	DYNC2H1 DYNC1H1	5.77e-04	14	48	2	IPR024317
Domain	COesterase	NLGN4X NLGN4Y	5.77e-04	14	48	2	PF00135
Domain	CARBOXYLESTERASE_B_2	NLGN4X NLGN4Y	5.77e-04	14	48	2	PS00941
Domain	CarbesteraseB	NLGN4X NLGN4Y	5.77e-04	14	48	2	IPR002018
Domain	AAA_8	DYNC2H1 DYNC1H1	5.77e-04	14	48	2	PF12780
Domain	AAA_5	DYNC2H1 DYNC1H1	5.77e-04	14	48	2	PF07728
Domain	-	PXDN LRRC31 LRRN2 PRAMEF2 FBXL6	1.36e-03	321	48	5	3.80.10.10
Domain	L_dom-like	PXDN LRRC31 LRRN2 PRAMEF2 FBXL6	1.49e-03	328	48	5	IPR032675
Domain	LRR_1	PXDN LRRC31 LRRN2 FBXL6	2.39e-03	219	48	4	PF00560
Domain	Leu-rich_rpt	PXDN LRRC31 LRRN2 FBXL6	5.11e-03	271	48	4	IPR001611
Domain	Cyt_P450_E_grp-I	CYP4A11 CYP4A22	5.97e-03	45	48	2	IPR002401
Domain	Cyt_P450_CS	CYP4A11 CYP4A22	8.20e-03	53	48	2	IPR017972
Domain	LRR_6	LRRC31 FBXL6	8.81e-03	55	48	2	PF13516
Domain	CYTOCHROME_P450	CYP4A11 CYP4A22	9.43e-03	57	48	2	PS00086
Domain	-	CYP4A11 CYP4A22	9.76e-03	58	48	2	1.10.630.10
Domain	p450	CYP4A11 CYP4A22	9.76e-03	58	48	2	PF00067
Pathway	WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES_PATHWAY	CYP4A11 CYP4A22	1.78e-04	9	32	2	M39819
Pathway	REACTOME_SYNTHESIS_OF_16_20_HYDROXYEICOSATETRAENOIC_ACIDS_HETE	CYP4A11 CYP4A22	2.71e-04	11	32	2	MM14863
Pathway	REACTOME_EICOSANOIDS	CYP4A11 CYP4A22	3.25e-04	12	32	2	M27129
Pathway	REACTOME_MISCELLANEOUS_SUBSTRATES	CYP4A11 CYP4A22	3.25e-04	12	32	2	M27128
Pathway	REACTOME_EICOSANOIDS	CYP4A11 CYP4A22	3.25e-04	12	32	2	MM14845
Pathway	WP_EICOSANOID_METABOLISM_VIA_CYTOCHROME_P450_MONOOXYGENASES	CYP4A11 CYP4A22	4.47e-04	14	32	2	MM15842
Pathway	REACTOME_FATTY_ACIDS	CYP4A11 CYP4A22	5.15e-04	15	32	2	M27126
Pathway	REACTOME_MISCELLANEOUS_SUBSTRATES	CYP4A11 CYP4A22	7.47e-04	18	32	2	MM14843
Pathway	REACTOME_FATTY_ACIDS	CYP4A11 CYP4A22	7.47e-04	18	32	2	MM14841
Pathway	WP_CILIOPATHIES	DYNC2H1 BBS4 KATNIP CCNQ	7.59e-04	184	32	4	M39880
Pubmed	Variable region genes in the human T-cell rearranging gamma (TRG) locus: V-J junction and homology with the mouse genes.	TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	2.01e-11	15	53	5	2969332
Pubmed	The human T-cell receptor gamma (TRG) genes.	TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	1.75e-10	22	53	5	2527426
Pubmed	Nardilysin convertase regulates the function of the maxi-K channel isoform mK44 in human myometrium.	NRDC KCNMA1	2.28e-06	2	53	2	19118164
Pubmed	Inhibition of microtubules and dynein rescues human immunodeficiency virus type 1 from owl monkey TRIMCyp-mediated restriction in a cellular context-specific fashion.	DYNC2H1 DYNC1H1	2.28e-06	2	53	2	25502651
Pubmed	Genetic analysis of the cytoplasmic dynein subunit families.	DYNC2H1 DYNC1H1	2.28e-06	2	53	2	16440056
Pubmed	The rat clofibrate-inducible CYP4A subfamily. II. cDNA sequence of IVA3, mapping of the Cyp4a locus to mouse chromosome 4, and coordinate and tissue-specific regulation of the CYP4A genes.	CYP4A11 CYP4A22	2.28e-06	2	53	2	2766933
Pubmed	Functional variant of CYP4A11 20-hydroxyeicosatetraenoic acid synthase is associated with essential hypertension.	CYP4A11 CYP4A22	2.28e-06	2	53	2	15611369
Pubmed	Autism Related Neuroligin-4 Knockout Impairs Intracortical Processing but not Sensory Inputs in Mouse Barrel Cortex.	NLGN4X NLGN4Y	2.28e-06	2	53	2	29106499
Pubmed	Perturbed Hippocampal Synaptic Inhibition and γ-Oscillations in a Neuroligin-4 Knockout Mouse Model of Autism.	NLGN4X NLGN4Y	2.28e-06	2	53	2	26456829
Pubmed	Nlgn4 knockout induces network hypo-excitability in juvenile mouse somatosensory cortex in vitro.	NLGN4X NLGN4Y	2.28e-06	2	53	2	24104404
Pubmed	20-HETE induces remodeling of renal resistance arteries independent of blood pressure elevation in hypertension.	CYP4A11 CYP4A22	2.28e-06	2	53	2	23825080
Pubmed	Salt-sensitive hypertension is associated with dysfunctional Cyp4a10 gene and kidney epithelial sodium channel.	CYP4A11 CYP4A22	2.28e-06	2	53	2	16691295
Pubmed	Deduced amino acid sequence of a murine cytochrome P-450 Cyp4a protein: developmental and hormonal regulation in liver and kidney.	CYP4A11 CYP4A22	2.28e-06	2	53	2	8031839
Pubmed	The P450 gene superfamily: recommended nomenclature.	CYP4A11 CYP4A22	2.28e-06	2	53	2	3829886
Pubmed	Human fatty acid omega-hydroxylase, CYP4A11: determination of complete genomic sequence and characterization of purified recombinant protein.	CYP4A11 CYP4A22	2.28e-06	2	53	2	10860550
Pubmed	A Cluster of Autism-Associated Variants on X-Linked NLGN4X Functionally Resemble NLGN4Y.	NLGN4X NLGN4Y	2.28e-06	2	53	2	32243781
Pubmed	Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4.	NLGN4X NLGN4Y	2.28e-06	2	53	2	22989184
Pubmed	Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice.	CYP4A11 CYP4A22	2.28e-06	2	53	2	29277328
Pubmed	Unusually rapid evolution of Neuroligin-4 in mice.	NLGN4X NLGN4Y	2.28e-06	2	53	2	18434543
Pubmed	Mouse Cyp4a isoforms: enzymatic properties, gender- and strain-specific expression, and role in renal 20-hydroxyeicosatetraenoic acid formation.	CYP4A11 CYP4A22	2.28e-06	2	53	2	17112342
Pubmed	Genetic polymorphism of CYP4A11 and CYP4A22 genes and in silico insights from comparative 3D modelling in a French population.	CYP4A11 CYP4A22	2.28e-06	2	53	2	21820496
Pubmed	Alterations in the regulation of androgen-sensitive Cyp 4a monooxygenases cause hypertension.	CYP4A11 CYP4A22	2.28e-06	2	53	2	11320253
Pubmed	Androgen-sensitive hypertension associates with upregulated vascular CYP4A12-20-HETE synthase.	CYP4A11 CYP4A22	2.28e-06	2	53	2	23641057
Pubmed	Characterization of the CYP4A11 gene, a second CYP4A gene in humans.	CYP4A11 CYP4A22	2.28e-06	2	53	2	12464262
Pubmed	Development of an autism severity score for mice using Nlgn4 null mutants as a construct-valid model of heritable monogenic autism.	NLGN4X NLGN4Y	2.28e-06	2	53	2	23183221
Pubmed	Juvenile manifestation of ultrasound communication deficits in the neuroligin-4 null mutant mouse model of autism.	NLGN4X NLGN4Y	2.28e-06	2	53	2	24855039
Pubmed	Renal function and vasomotor activity in mice lacking the Cyp4a14 gene.	CYP4A11 CYP4A22	2.28e-06	2	53	2	20943934
Pubmed	The Blood Pressure-Lowering Effect of 20-HETE Blockade in Cyp4a14(-/-) Mice Is Associated with Natriuresis.	CYP4A11 CYP4A22	2.28e-06	2	53	2	28912346
Pubmed	High-fat diet-induced obesity and insulin resistance in CYP4a14-/- mice is mediated by 20-HETE.	CYP4A11 CYP4A22	2.28e-06	2	53	2	30088983
Pubmed	Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta.	CYP4A11 CYP4A22	2.28e-06	2	53	2	15066132
Pubmed	Sex-specific microglia state in the Neuroligin-4 knock-out mouse model of autism spectrum disorder.	NLGN4X NLGN4Y	2.28e-06	2	53	2	37001827
Pubmed	Altered inflammatory responses to Citrobacter rodentium infection, but not bacterial lipopolysaccharide, in mice lacking the Cyp4a10 or Cyp4a14 genes.	CYP4A11 CYP4A22	2.28e-06	2	53	2	24413902
Pubmed	Increased Network Inhibition in the Dentate Gyrus of Adult Neuroligin-4 Knock-Out Mice.	NLGN4X NLGN4Y	2.28e-06	2	53	2	37080762
Pubmed	Mechanisms of podocyte injury in diabetes: role of cytochrome P450 and NADPH oxidases.	CYP4A11 CYP4A22	2.28e-06	2	53	2	19208908
Pubmed	Expression of murine cyclin B1 mRNAs and genetic mapping of related genomic sequences.	CYP4A11 CYP4A22 PNP	2.68e-06	18	53	3	1387105
Pubmed	Analysis of the neuroligin 4Y gene in patients with autism.	NLGN4X NLGN4Y	6.83e-06	3	53	2	18628683
Pubmed	Competitive oxidation and ubiquitylation on the evolutionarily conserved cysteine confer tissue-specific stabilization of Insig-2.	AMFR INSIG1	6.83e-06	3	53	2	31953408
Pubmed	Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis.	CYP4A11 CYP4A22	6.83e-06	3	53	2	28270609
Pubmed	Mammalian cells express three distinct dynein heavy chains that are localized to different cytoplasmic organelles.	DYNC2H1 DYNC1H1	6.83e-06	3	53	2	8666668
Pubmed	The P450 superfamily: update on new sequences, gene mapping, and recommended nomenclature.	CYP4A11 CYP4A22	6.83e-06	3	53	2	1991046
Pubmed	Genetic analysis of resistance to radiation lymphomagenesis with recombinant inbred strains of mice.	CYP4A11 CYP4A22	6.83e-06	3	53	2	2354437
Pubmed	Recombinant human cytoplasmic dynein heavy chain 1 and 2: observation of dynein-2 motor activity in vitro.	DYNC2H1 DYNC1H1	6.83e-06	3	53	2	21723285
Pubmed	Evolution of the Autism-Associated Neuroligin-4 Gene Reveals Broad Erosion of Pseudoautosomal Regions in Rodents.	NLGN4X NLGN4Y	6.83e-06	3	53	2	32011705
Pubmed	Sterol-regulated degradation of Insig-1 mediated by the membrane-bound ubiquitin ligase gp78.	AMFR INSIG1	6.83e-06	3	53	2	17043353
Pubmed	Increased renal proximal convoluted tubule transport contributes to hypertension in Cyp4a14 knockout mice.	CYP4A11 CYP4A22	6.83e-06	3	53	2	19713718
Pubmed	Mouse cathepsin D gene: molecular organization, characterization of the promoter, and chromosomal localization.	CYP4A11 CYP4A22	6.83e-06	3	53	2	8011168
Pubmed	Peroxisome proliferator activated receptor alpha regulates a male-specific cytochrome P450 in mouse liver.	CYP4A11 CYP4A22	6.83e-06	3	53	2	15313227
Pubmed	Pathogenic variants of DYNC2H1, KIAA0556, and PTPN11 associated with hypothalamic hamartoma.	DYNC2H1 KATNIP	6.83e-06	3	53	2	31197031
Pubmed	Differential regulation of HMG-CoA reductase and Insig-1 by enzymes of the ubiquitin-proteasome system.	AMFR INSIG1	6.83e-06	3	53	2	23087214
Pubmed	Cytoplasmic dynein promotes HIV-1 uncoating.	DYNC2H1 DYNC1H1	6.83e-06	3	53	2	25375884
Pubmed	H19/Mir-130b-3p/Cyp4a14 potentiate the effect of praziquantel on liver in the treatment of Schistosoma japonicum infection.	CYP4A11 CYP4A22	6.83e-06	3	53	2	37659685
Pubmed	Neuroligin-4 is localized to glycinergic postsynapses and regulates inhibition in the retina.	NLGN4X NLGN4Y	6.83e-06	3	53	2	21282647
Pubmed	Cholesterol and fatty acids regulate cysteine ubiquitylation of ACAT2 through competitive oxidation.	AMFR INSIG1	6.83e-06	3	53	2	28604676
Pubmed	A novel murine P-450 gene, Cyp4a14, is part of a cluster of Cyp4a and Cyp4b, but not of CYP4F, genes in mouse and humans.	CYP4A11 CYP4A22	6.83e-06	3	53	2	9271096
Pubmed	Analysis of four neuroligin genes as candidates for autism.	NLGN4X NLGN4Y	1.36e-05	4	53	2	16077734
Pubmed	Neuroligins 3 and 4X interact with syntrophin-gamma2, and the interactions are affected by autism-related mutations.	NLGN4X NLGN4Y	1.36e-05	4	53	2	17292328
Pubmed	Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism.	NLGN4X NLGN4Y	1.36e-05	4	53	2	12669065
Pubmed	Homodimerization and isoform-specific heterodimerization of neuroligins.	NLGN4X NLGN4Y	1.36e-05	4	53	2	22671294
Pubmed	Murine c-mpl: a member of the hematopoietic growth factor receptor superfamily that transduces a proliferative signal.	CYP4A11 CYP4A22	1.36e-05	4	53	2	8334987
Pubmed	Ultrasonic vocalizations in mouse models for speech and socio-cognitive disorders: insights into the evolution of vocal communication.	NLGN4X NLGN4Y	1.36e-05	4	53	2	20579107
Pubmed	Gp78, a membrane-anchored ubiquitin ligase, associates with Insig-1 and couples sterol-regulated ubiquitination to degradation of HMG CoA reductase.	AMFR INSIG1	1.36e-05	4	53	2	16168377
Pubmed	Mapping of the azh locus to mouse chromosome 4.	CYP4A11 CYP4A22	1.36e-05	4	53	2	1552159
Pubmed	Differences in metabolite burden of di(2-ethylhexyl)phthalate in pregnant and postpartum dams and their offspring in relation to drug-metabolizing enzymes in mice.	CYP4A11 CYP4A22	1.36e-05	4	53	2	22159897
Pubmed	Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob/ob mice, and fa/fa Zucker rats.	CYP4A11 CYP4A22	1.36e-05	4	53	2	10049703
Pubmed	Salt modulates vascular response through adenosine A(2A) receptor in eNOS-null mice: role of CYP450 epoxygenase and soluble epoxide hydrolase.	CYP4A11 CYP4A22	1.36e-05	4	53	2	21161333
Pubmed	The E3 ubiquitin ligase AMFR and INSIG1 bridge the activation of TBK1 kinase by modifying the adaptor STING.	AMFR INSIG1	1.36e-05	4	53	2	25526307
Pubmed	Sterol-induced degradation of HMG CoA reductase depends on interplay of two Insigs and two ubiquitin ligases, gp78 and Trc8.	AMFR INSIG1	2.27e-05	5	53	2	22143767
Pubmed	Species-specific induction of cytochrome P-450 4A RNAs: PCR cloning of partial guinea-pig, human and mouse CYP4A cDNAs.	CYP4A11 CYP4A22	2.27e-05	5	53	2	8363569
Pubmed	Neuroligins and neurexins link synaptic function to cognitive disease.	NLGN4X NLGN4Y	2.27e-05	5	53	2	18923512
Pubmed	Synapse formation: if it looks like a duck and quacks like a duck ...	NLGN4X NLGN4Y	2.27e-05	5	53	2	10996085
Pubmed	Post-translational regulation of lipogenesis via AMPK-dependent phosphorylation of insulin-induced gene.	AMFR INSIG1	2.27e-05	5	53	2	30733434
Pubmed	Modulation by salt intake of the vascular response mediated through adenosine A(2A) receptor: role of CYP epoxygenase and soluble epoxide hydrolase.	CYP4A11 CYP4A22	2.27e-05	5	53	2	20427718
Pubmed	Mapping of guanylin to murine chromosome 4 and human chromosome 1p34-p35.	CYP4A11 CYP4A22	2.27e-05	5	53	2	7601480
Pubmed	Multiple N-linked glycosylation sites critically modulate the synaptic abundance of neuroligin isoforms.	NLGN4X NLGN4Y	2.27e-05	5	53	2	37865312
Pubmed	Genesis, a winged helix transcriptional repressor with expression restricted to embryonic stem cells.	CYP4A11 CYP4A22	3.40e-05	6	53	2	8798505
Pubmed	Organization of the distal end of mouse chromosome 4.	CYP4A11 CYP4A22	3.40e-05	6	53	2	3166417
Pubmed	The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?	NLGN4X NLGN4Y	3.40e-05	6	53	2	21838267
Pubmed	Peroxisome proliferator-activated receptor-α accelerates α-chlorofatty acid catabolism.	CYP4A11 CYP4A22	3.40e-05	6	53	2	28007964
Pubmed	Mouse uroporphyrinogen decarboxylase: cDNA cloning, expression, and mapping.	CYP4A11 CYP4A22	3.40e-05	6	53	2	8661721
Pubmed	Autism-associated neuroligin-4 mutation selectively impairs glycinergic synaptic transmission in mouse brainstem synapses.	NLGN4X NLGN4Y	3.40e-05	6	53	2	29724786
Pubmed	Peroxisome proliferator-activated receptor alpha-responsive genes induced in the newborn but not prenatal liver of peroxisomal fatty acyl-CoA oxidase null mice.	CYP4A11 CYP4A22	3.40e-05	6	53	2	11461119
Pubmed	Unsaturated fatty acids inhibit proteasomal degradation of Insig-1 at a postubiquitination step.	AMFR INSIG1	3.40e-05	6	53	2	18835813
Pubmed	Ancient ubiquitous protein-1 mediates sterol-induced ubiquitination of 3-hydroxy-3-methylglutaryl CoA reductase in lipid droplet-associated endoplasmic reticulum membranes.	AMFR INSIG1	3.40e-05	6	53	2	23223569
Pubmed	Erlins restrict SREBP activation in the ER and regulate cellular cholesterol homeostasis.	AMFR INSIG1	4.76e-05	7	53	2	24217618
Pubmed	Activation of PPAR-alpha in streptozotocin-induced diabetes is essential for resistance against acetaminophen toxicity.	CYP4A11 CYP4A22	4.76e-05	7	53	2	12958197
Pubmed	Perfluorocarboxylic acids induce cytochrome P450 enzymes in mouse liver through activation of PPAR-alpha and CAR transcription factors.	CYP4A11 CYP4A22	4.76e-05	7	53	2	18648086
Pubmed	Molecular mapping of the mouse db mutation.	CYP4A11 CYP4A22	4.76e-05	7	53	2	1978328
Pubmed	Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways.	NLGN4X NLGN4Y	6.34e-05	8	53	2	30871858
Pubmed	Diversity and rearrangement of the human T cell rearranging gamma genes: nine germ-line variable genes belonging to two subgroups.	TRGV2 TRGV3	6.34e-05	8	53	2	2938743
Pubmed	HIV-1 uncoating is facilitated by dynein and kinesin 1.	DYNC2H1 DYNC1H1	6.34e-05	8	53	2	25231297
Pubmed	Microdissection and microcloning of mid-chromosome 4: genetic mapping of 41 microdissection clones.	CYP4A11 CYP4A22	6.34e-05	8	53	2	8098006
Pubmed	Drug metabolizing enzyme induction pathways in experimental non-alcoholic steatohepatitis.	CYP4A11 CYP4A22	6.34e-05	8	53	2	18488193
Pubmed	The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature.	CYP4A11 CYP4A22	8.15e-05	9	53	2	7678494
Pubmed	Using mouse models of autism spectrum disorders to study the neurotoxicology of gene-environment interactions.	NLGN4X NLGN4Y	8.15e-05	9	53	2	23010509
Pubmed	Mapping genes encoding drug-metabolizing enzymes in recombinant inbred mice.	CYP4A11 CYP4A22	8.15e-05	9	53	2	1685137
Pubmed	Microglia ablation alleviates myelin-associated catatonic signs in mice.	NLGN4X NLGN4Y	8.15e-05	9	53	2	29252214
Pubmed	Genetic mapping of meander tail, a mouse mutation affecting cerebellar development.	CYP4A11 CYP4A22	1.02e-04	10	53	2	2037292
Pubmed	SPARCL1 Promotes Excitatory But Not Inhibitory Synapse Formation and Function Independent of Neurexins and Neuroligins.	NLGN4X NLGN4Y	1.24e-04	11	53	2	32973045
Pubmed	Behavioral phenotypes of genetic mouse models of autism.	NLGN4X NLGN4Y	1.24e-04	11	53	2	26403076
Pubmed	The Meckel syndrome- associated protein MKS1 functionally interacts with components of the BBSome and IFT complexes to mediate ciliary trafficking and hedgehog signaling.	DYNC2H1 BBS4	1.24e-04	11	53	2	28291807
Interaction	CYP4A22 interactions	CYP4A11 CYP4A22	1.59e-05	3	47	2	int:CYP4A22
Cytoband	7p14	TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	2.35e-10	30	53	5	7p14
Cytoband	Ensembl 112 genes in cytogenetic band chr7p14	TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	1.83e-06	174	53	5	chr7p14
Cytoband	1p33	CYP4A11 CYP4A22	7.59e-04	35	53	2	1p33
Cytoband	Ensembl 112 genes in cytogenetic band chr16q13	AMFR RSPRY1	9.92e-04	40	53	2	chr16q13
Cytoband	Ensembl 112 genes in cytogenetic band chr1p33	CYP4A11 CYP4A22	2.29e-03	61	53	2	chr1p33
GeneFamily	T cell receptor gamma locus at 7p14	TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	3.23e-10	22	32	5	375
GeneFamily	Dyneins, cytoplasmic	DYNC2H1 DYNC1H1	2.34e-04	13	32	2	538
GeneFamily	Cytochrome P450 family 4	CYP4A11 CYP4A22	1.84e-03	36	32	2	1003
ToppCell	Transverse-T_cell-gd_T\|Transverse / Region, Cell class and subclass	PXDN TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	1.34e-07	199	53	6	92554fddd887fe6c1c943ed704d4a02c999ba830
ToppCell	Transverse-(1)_T_cell-(17)_gd_T\|Transverse / shred on region, Cell_type, and subtype	PXDN TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	1.34e-07	199	53	6	a3a29ed65881f1dcf09b2fec8788161ea3adef48
ToppCell	COVID-19_Severe-CD4+_CTL\|World / disease group, cell group and cell class	TRGV2 TRGV3 TRGV4 TRGV10 CATSPERB	1.75e-06	169	53	5	8c8168ac93a808d7b4756e4491db2b2979df1c1f
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|lymph-node_spleen / Manually curated celltypes from each tissue	UTS2 TRGV2 TRGV3 TRGV4 TRGV5	3.02e-06	189	53	5	e8ff2c4fd2481bfbc99a5a6f02e0db8c995b3a23
ToppCell	saliva-Severe-critical_progression_d28-40-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	UTS2 INSIG1 NAGLU KCNMA1 PLBD2	3.02e-06	189	53	5	0a490730cdc912d5233de59057550de0e4065747
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-Th17\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TRGV2 TRGV3 TRGV4 TRGV5 PNP	3.35e-06	193	53	5	4112eed9327e1d5a7e829fce6b2437287e14464e
ToppCell	COVID-19-Lymphoid-CD8_T_cells\|Lymphoid / Condition, Lineage and Cell class	TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	3.52e-06	195	53	5	d4c70a462b98963e78f4e2659574bc350f8ffe1a
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD3-NKT\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	3.89e-06	199	53	5	40f9f771004850be477ee491a7a74c74b84074ab
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD3\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV5 TRGV10	3.89e-06	199	53	5	eb30711ab34510429b644498ecfab4ec3cb61cbc
ToppCell	Severe-CD8+_T\|Severe / Disease group and Cell class	TRGV2 TRGV3 TRGV4 TRGV10	4.64e-06	93	53	4	433d23253b2102cf65df338a488554e5ab409d7e
ToppCell	LPS-antiTNF-Stromal_mesenchymal-Fibroblasts-Monocytes-Macrophages\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	KIAA0513 TMEM184C F8 TDRD12	3.14e-05	151	53	4	f13a117ae26ae525da4f3e837d8f204d00dc6ee3
ToppCell	10x5'-Lung-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|Lung / Manually curated celltypes from each tissue	TRGV2 TRGV3 TRGV4 TRGV5	3.57e-05	156	53	4	0ea6ca3f38109151a2a4fdf63a4f009929cdcc40
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYNC2H1 SYDE2 TAS1R1 LRRN2	3.75e-05	158	53	4	12661763d1c309106801cb710c04cd2b62d16cba
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial-TECs\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYNC2H1 SYDE2 TAS1R1 LRRN2	3.75e-05	158	53	4	0792c39e6fc0745095af7812de2d50949540d60f
ToppCell	facs-Thymus-Thymus_Flowthrough-18m-Epithelial-epithelial_cell_of_thymus\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	DYNC2H1 SYDE2 TAS1R1 LRRN2	3.75e-05	158	53	4	e7db50d6dfaf7280a73a0d5b5aa4f43ea2762d72
ToppCell	5'-Adult-Appendix-Hematopoietic-T_cells-TRGV2_gdT\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	FAT2 UTS2 TRGV2 TRGV4	4.87e-05	169	53	4	8caf7996796a2e2716e3855de855c903d6126bf2
ToppCell	COVID-19_Severe-CD4+_CTL\|COVID-19_Severe / disease group, cell group and cell class	TRGV2 TRGV3 TRGV10 CATSPERB	5.83e-05	177	53	4	34e9455790bae905dd91923792f4109d18b7686e
ToppCell	5'-GW_trimst-2-LymphNode-Hematopoietic-T_cells-TRDV2/TRGV9_gdT\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRGV2 TRGV3 TRGV4 TRGV5	6.09e-05	179	53	4	f7d3d37505893ae55065c89d957084602729decc
ToppCell	COVID-19-Heart-Fib_+_EC_+_Pericyte\|COVID-19 / Disease (COVID-19 only), tissue and cell type	PXDN NLGN4X ACSM1 F8	6.50e-05	182	53	4	fbd5e332df73bf7141c822fa67b76367dc962017
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT2\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TRGV2 TRGV3 TRGV4 TRGV5	6.92e-05	185	53	4	2d95713deaa05fb3372f4337ef156027e4d8ec8a
ToppCell	facs-Brain_Non-Myeloid-Cerebellum-24m-Neuronal-interneuron\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	FAT2 KIAA0513 STXBP5L BRSK2	7.07e-05	186	53	4	d1d01ce46e62944aa9864eda47e8401b5f0d2bdc
ToppCell	LV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	NLGN4X DYNC2H1 ACSM1 CATSPERB	7.68e-05	190	53	4	12992ec80a7b4f4f17de693f0719ee061a9918fd
ToppCell	wk_20-22-Hematologic_Lymphocytic-T_&_ILC-NKT1\|wk_20-22 / Celltypes from embryonic and fetal-stage human lung	TRGV2 TRGV3 TRGV4 TRGV5	7.68e-05	190	53	4	326002d7f9de5e425cee76d9a0277f42d79058e2
ToppCell	LV-02._Fibroblast_II\|World / Chamber and Cluster_Paper	NLGN4X NLGN4Y ACSM1 CATSPERB	7.83e-05	191	53	4	d36565257ccba8c1bbed2c1c01be66a9cbb5f834
ToppCell	RV-01._Fibroblast_I\|World / Chamber and Cluster_Paper	NLGN4X DYNC2H1 ACSM1 CATSPERB	7.83e-05	191	53	4	70c067c54084bfb02c29bab085f4defd477194fb
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	UTS2 TRGV2 TRGV4 TRGV5	7.99e-05	192	53	4	ab88ea7723f0fa3b39611981c043445f27425404
ToppCell	RV-01._Fibroblast_I\|RV / Chamber and Cluster_Paper	NLGN4X DYNC2H1 ACSM1 CATSPERB	7.99e-05	192	53	4	356160b113c3305a61ceeaff33ce3c9da0be2878
ToppCell	LV-01._Fibroblast_I\|LV / Chamber and Cluster_Paper	NLGN4X DYNC2H1 ACSM1 CATSPERB	8.15e-05	193	53	4	dc17f3b9758936d428cf17f77a1ce6d4c479b165
ToppCell	wk_15-18-Hematologic_Lymphocytic-T_&_ILC-NKT2\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	TRGV2 TRGV3 TRGV4 TRGV5	8.15e-05	193	53	4	bae37ec161fad7c91edc674a2c7808b51c9a8135
ToppCell	Mild-CD8+_T\|World / Disease group and Cell class	TRGV2 TRGV3 TRGV4 TRGV5	8.32e-05	194	53	4	d64c2efb482bcdef9240977eae1023c4191286e7
ToppCell	COVID-19-Heart-Fib_1\|Heart / Disease (COVID-19 only), tissue and cell type	PXDN NLGN4X DYNC2H1 ACSM1	8.49e-05	195	53	4	f423baa36ac7cdc383c033e35a7d17e6bf913323
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_cytotoxic_T_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	TRGV2 TRGV3 TRGV4 TRGV10	8.49e-05	195	53	4	730c613cf6f4d16ca51fd44de1f5a883f615c5c5
ToppCell	5'-GW_trimst-2-SmallIntestine-Hematopoietic-T_cells-TRDV2/TRGV9_gdT\|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	TRGV2 TRGV3 TRGV4 TRGV5	8.65e-05	196	53	4	8e20ffe39157619b1d02b48d2cf9d62f26bdb3e8
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRGV2 TRGV3 TRGV4 TRGV10	8.83e-05	197	53	4	cd39574b5a81a361a7940c4eb26e82652addc9e9
ToppCell	BAL-Severe-Lymphocyte-T/NK-CD8+_T-CD8+_T-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRGV2 TRGV3 TRGV4 TRGV10	8.83e-05	197	53	4	4946a9495ee8824540c4b45bd2a1a75696b71534
ToppCell	mild_COVID-19_(asymptomatic)-CD4+_CTL\|World / disease group, cell group and cell class (v2)	TRGV2 TRGV3 TRGV4 TRGV10	9.00e-05	198	53	4	03c01fc384d46eec55ff730edbab8a3fde618ed8
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD3-NKT\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV10	9.18e-05	199	53	4	8a64437fecdf0b13247f2582bd2ab55ab58f8066
ToppCell	VE-CD8\|VE / Condition, Cell_class and T cell subcluster	TRGV2 TRGV3 TRGV4 TRGV10	9.18e-05	199	53	4	9ae4d3e93b6e0861258e567c901ec34f04ded547
ToppCell	Tracheal-10x5prime-Immune_Lymphocytic-T\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV10	9.18e-05	199	53	4	f53190b7e236b46a7ffca52977b9ad39831f66f4
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD8+_T\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	TRGV2 TRGV3 TRGV4 TRGV10	9.18e-05	199	53	4	3005f9d8c33848d8eff261e482d1485a7aa99137
ToppCell	cellseq-Immune-Lymphocytic_T/NK-Lymphocytic_T/NK-CD8_T\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	TRGV2 TRGV3 TRGV4 TRGV10	9.18e-05	199	53	4	f96a6b95329ec6642b3a528c9e346ab3e1733c25
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	TRGV2 TRGV3 TRGV4 TRGV10	9.18e-05	199	53	4	7b8678ab14b72d831e991223b45df520476d555f
ToppCell	Transverse-T_cell-gd_T\|T_cell / Region, Cell class and subclass	TRGV2 TRGV3 TRGV4 TRGV5	9.18e-05	199	53	4	8baea162803cea7d72dff5866a0eebfcf2e5dcd6
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD8+_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	TRGV2 TRGV3 TRGV4 TRGV10	9.18e-05	199	53	4	518b734c13cfc0879d05a05eff47490fc8246d96
ToppCell	Mild_COVID-19-T/NK-CD8+_T\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	TRGV2 TRGV3 TRGV4 TRGV10	9.18e-05	199	53	4	27a1b62e270cad1defa80f04f4ee5b5c8e448792
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD3\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV10	9.18e-05	199	53	4	3bf6d35e0f9be58f01a0b43cb707635595186bb0
ToppCell	BAL-Mild-Lymphocyte-T/NK-CD8+_T-CD8+_T\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	TRGV2 TRGV3 TRGV4 TRGV10	9.18e-05	199	53	4	b154226a8b074b5c8be3e7c6c3a850839c7088da
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-T-T_CD8-MAIT\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	UTS2 PIK3CD TRGV3 TRGV10	9.18e-05	199	53	4	036776a03fdd181e51cc655ed99331eec9c63f39
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-gdT\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV10	9.36e-05	200	53	4	f62e594b076fdfa63a425f424da204203777e7c9
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_TRM\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV10	9.36e-05	200	53	4	117c8154375b137e8e4453f294c083a0973a97d5
ToppCell	Parenchymal-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_CTL\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV10	9.36e-05	200	53	4	b76f000582b38f4c61b44081eba9ae213382cb6f
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV10	9.36e-05	200	53	4	8b8c07a16c91bd6e0d276fba1472d0d314e03416
ToppCell	Bronchial-10x5prime-Immune_Lymphocytic-T-T_CD8-CD8_CTL\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	TRGV2 TRGV3 TRGV4 TRGV10	9.36e-05	200	53	4	dc719c7f0ffee0db4f56f1991e47974dc7bef11b
ToppCell	(17)_gd_T\|World / shred on Cell_type and subtype	TRGV2 TRGV4 TRGV5 TRGV10	9.54e-05	201	53	4	7fcfe48758acf07cb3dda939ce589ae1518e41c9
Disease	X-14939 measurement	CYP4A11 CYP4A22	3.55e-05	6	46	2	EFO_0800747
Disease	response to antipsychotic drug	DYNC2H1 STXBP5L PNP	1.14e-04	60	46	3	GO_0097332
Disease	autosomal recessive polycystic kidney disease (biomarker_via_orthology)	CYP4A11 CYP4A22	1.30e-04	11	46	2	DOID:0110861 (biomarker_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
PISLWVILQHLVHYT	TMEM184C	61	Q9NVA4
RKVESLWPIFRIHHQ	BUD31	41	P41223
LWPIFRIHHQKTRYI	BUD31	46	P41223
ILEKQNWLIHLHYIR	BBS4	31	Q96RK4
WLVRITLHHGLNIYA	CATSPERB	131	Q9H7T0
RYLLTLHPVWSQQHR	GPR33	126	Q49SQ1
VLLSIYGLHHNPKVW	CYP4A11	411	Q02928
LQRLTLIHWKSQVHP	FBXL6	196	Q8N531
WVRQLKYHLGSPHII	DNHD1	1601	Q96M86
PHKYLLHYLVSLQNW	CCNQ	141	Q8N1B3
PSWHIKQLYLQHRVL	NAGLU	216	P54802
LYTHLKQQPIWHTLR	KIAA0513	291	O60268
LVDHPNIVKLHKYWL	NRBP2	96	Q9NSY0
LQYHNKAHLLNIPSW	KCNMA1	526	Q12791
HPCHVALIRIWNYNK	KATNIP	1066	O60303
LRVQETHPYHILLSW	LRRN2	531	O75325
ARRLTLEHIQKHIWY	BRSK2	256	Q8IWQ3
ARNWHIHFYLKTLQP	FAT2	3791	Q9NYQ8
WFRHLLYAVTKLPQI	LRRC31	501	Q6UY01
YPNTWHHRLLQRSLV	INSIG1	76	O15503
LTRYLRIHPQSWVHQ	F8	2321	P00451
KVAFWLELVPHLHNL	NLGN4Y	586	Q8NFZ3
NLNHIQRKWVYLEPI	DYNC2H1	1341	Q8NCM8
KSWLIYHNQHVLVTP	SERPINA2	66	P20848
VLLSIYGLHHNPKVW	CYP4A22	411	Q5TCH4
WIKLDYHRRHNPKTN	IQUB	386	Q8NA54
NWLHLIPQTLSHLKR	DYNC1H1	4386	Q14204
KVAFWLELVPHLHNL	NLGN4X	586	Q8N0W4
WLLSHTKHRPQVAII	PNP	16	P00491
AWHIRLKQYHPVVEA	RSBN1	696	Q5VWQ0
HIEVLHYLLQLWPVQ	SYDE2	1016	Q5VT97
HYLLQLWPVQRLTVK	SYDE2	1021	Q5VT97
NILLSHLLARIWKPY	UTS2	96	O95399
QLIWYNARSKPHIHP	RSPRY1	406	Q96DX4
IHWYLHQEGKAPQRL	TRGV2	51	A0A075B6R0
ALLPHKGNILSYWIR	TMEM126A	136	Q9H061
IEWNPKVTRYIHHKI	TDRD12	1011	Q587J7
EQPKNYQVWHHRRVL	FNTA	161	P49354
IHWYLHQEGKAPQRL	TRGV3	51	P03979
IHWYLHQEGKAPQRL	TRGV5	51	A0A0B4J1U4
EIHNTCWPHLIRKLY	PRAMEF2	211	O60811
PQWALAQHQTKLYLL	MLH1	536	P40692
HLWNLRQKRPAILHS	STXBP5L	136	Q9Y2K9
AHVILRYVIHLWDLN	AMFR	231	Q9UKV5
VIIQTLLKYPINHFW	ACSM1	301	Q08AH1
VYPWQLLEQIHKVHF	TAS1R1	416	Q7RTX1
IQHITYQHWLPKILG	PXDN	1026	Q92626
VIHWYRQKPNQALEH	TRGV10	51	A0A0A0MS01
QHYRVKPLHYISWLV	NRDC	451	O43847
KQLLWHRAQYEPLFH	PIK3CD	46	O00329
IHWYLHQEGKAPQRL	TRGV4	51	A0A0C4DH28
SPYWHQVRLTLLQLK	PLBD2	176	Q8NHP8
ELLTQHWHLKTPNLV	TRPM8	131	Q7Z2W7
HPLNKLQEAWRSIHY	SMYD5	146	Q6GMV2
IKRHIRQKHPYSLHW	ZFTA	141	C9JLR9